Merck Sharp & Dohme Llc
Clinical trials sponsored by Merck Sharp & Dohme Llc, explained in plain language.
-
Major lung cancer trial halted early after failing to show clear benefit
Disease control TerminatedThis study tested whether adding an immunotherapy drug (pembrolizumab) to a precise form of radiation (SBRT) was better at controlling early-stage lung cancer than radiation alone. It involved 448 adults with early-stage lung cancer who could not have or chose not to have surgery…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Monthly pill trial aims to stop HIV before it starts
Prevention TerminatedThis study aimed to see if a new monthly oral pill (islatravir) could prevent HIV infection in women at high risk. It compared the monthly pill to a standard daily medication (FTC/TDF). The trial was stopped early for safety monitoring after lab tests showed potential effects on …
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Apr 01, 2026 14:41 UTC